This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Fresenius Kabi USA, LLC
Fresenius Kabi USA, LLC, a prominent subsidiary of Fresenius Kabi AG, is headquartered in the United States and operates extensively across North America. Founded in 1996, the company has established itself as a leader in the healthcare industry, specialising in lifesaving medicines and technologies. Fresenius Kabi focuses on critical care, infusion therapy, and biosimilars, offering a diverse range of products that are distinguished by their quality and reliability. With a commitment to enhancing patient care, Fresenius Kabi has achieved significant milestones, including the development of innovative drug delivery systems and a robust portfolio of intravenous solutions. The company is recognised for its strong market position, consistently ranking among the top providers in its field, and is dedicated to advancing healthcare through sustainable practices and cutting-edge research.
DitchCarbon Score
How does Fresenius Kabi USA, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Fresenius Kabi USA, LLC's score of 46 is higher than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Fresenius Kabi USA, LLC, headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Fresenius SE & Co. KGaA, which cascades emissions data and climate commitments from its parent organisation. As of now, there are no documented reduction targets or climate pledges specific to Fresenius Kabi USA, LLC. The absence of specific initiatives or targets indicates a potential area for development in their sustainability strategy. The emissions data and performance metrics are inherited from Fresenius SE & Co. KGaA, which operates under broader industry standards for climate action. This relationship suggests that any climate commitments or emissions reductions would align with the overarching goals set by the parent company. In summary, while Fresenius Kabi USA, LLC does not currently report specific emissions figures or reduction targets, it is part of a larger corporate structure that may influence its future climate commitments and sustainability initiatives.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 521,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 1,013,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Fresenius Kabi USA, LLC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
